Filing Details
- Accession Number:
- 0001140361-18-009970
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-23 20:38:04
- Reporting Period:
- 2018-02-21
- Accepted Time:
- 2018-02-23 20:38:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1301501 | Achaogen Inc | AKAO | Pharmaceutical Preparations (2834) | 680533693 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1678984 | Tobin Schilke | C/O Achaogen, Inc. 1 Tower Place, Suite 300 South San Francisco CA 94080 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-21 | 1,108 | $10.67 | 40,185 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") of the Issuer.
- Includes (i) 1,174 shares acquired under the issuer's Employee Stock Purchase Plan on November 30, 2017 and (ii) 30,225 Restricted Stock Units.
Billionaire Hedge Funds
